RIGI and glioblastoma: In a recent mini-review, the role of retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and type I IFNs in the treatment of glioblastoma (GB), a common aggressive primary adult brain cancer, was assessed [34].